AVITA Medical, Inc. (RCEL) Inventory (2018 - 2026)

AVITA Medical (RCEL) has reported Inventory for 9 consecutive years, with $5.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory fell 29.84% year-over-year to $5.3 million; the trailing twelve-month figure through Jun 2026 stood at $5.3 million (down 29.84% YoY), and the FY2025 full-year result was $6.9 million, down 4.72% from the prior year.
• Inventory retreated to $5.3 million in Q2 2026 per RCEL's latest filing, from $6.9 million in the prior quarter.
• Across five years, Inventory topped out at $8.4 million in Q1 2025 and bottomed at $1.8 million in Q1 2022.
• Historically, Inventory has averaged $5.1 million across 5 years, with a median of $5.6 million in 2023.
• The sharpest annual moves came in 2023 and 2026: Inventory surged 163.34% in 2023, then slipped 29.84% in 2026.
• Over 5 years, Inventory stood at $2.1 million in 2022, then soared by 163.34% to $5.6 million in 2023, then gained by 29.9% to $7.3 million in 2024, then retreated by 4.72% to $6.9 million in 2025, then dropped by 23.66% to $5.3 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $5.3 million, $6.9 million, and $7.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.